JPRN-UMIN000002602
Recruiting
Phase 1
Phase I/II trial of combination chemotherapy using TS-1, CPT-11 and cetuximab with radiation in locally advanced rectal cancer - Phase I/II trial of combination chemotherapy using TS-1, CPT-11 and cetuximab with radiation in locally advanced rectal cancer
Yokohama City University Graduate School of Medicine0 sites35 target enrollmentOctober 9, 2009
ConditionsRectal cancer
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Rectal cancer
- Sponsor
- Yokohama City University Graduate School of Medicine
- Enrollment
- 35
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients were excluded if they had prior RT to the pelvic region or previous cytotoxic chemotherapy or if they had other synchronous cancers. Patients suffering from the following conditions were also ineligible: inflammatory bowel disease, malabsorption syndrome, ischemic heart disease, peripheral neuropathy, and psychiatric disorders or psychologic disabilities thought to adversely affect treatment compliance. In addition, pregnant or lactating patients and women with childbearing potential who lacked effective contraception were excluded.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
Phase I-II study of combination chemotherapy with Irinotecan and Gemcitabine for clear cell or mucinous ovarian cancerClear cell or mucinous ovarian cancerJPRN-UMIN000005952Osaka university, faculty of medicine40
Active, not recruiting
Not Applicable
.A phase ll trial of combination chemotherapy with intravenous oxaliplatin combined with tablet capecitabin in patients with recidivant breastcancerbreastcancer with metastasesMedDRA version: 16.0Level: PTClassification code 10006202Term: Breast cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2012-005329-56-DKDept of oncology50
Completed
Phase 1
Phase I/II study of combination chemotherapy with Paclitaxel and TS-1 and Cisplatin for unresectable/ recurrent gastric cancerunresectable or recurrent gastric cancerJPRN-UMIN000004729School of Medicine, Keio University40
Completed
Phase 2
A Phase II Study of Combination Chemotherapy using TS-1 and Cisplatin with Concurrent Thoracic Radiotherapy for Locally Advanced Non-Small Cell Lung CancerJPRN-UMIN000001370West Japan Oncology Group55
Completed
Phase 1
A phase I study of the combination chemotherapy of IRISOX (irinotecan/S-1/oxaliplatin) in gemcitabine-refractory pancreatic cancergemcitabine-refractory pancreatic cancerJPRN-UMIN000022964Kitasato University School of Medicine12